Product Information
LEVO-T 25 MCG TABLET is a generic product labeled by Neolpharma, Inc., priced at $0.0362 per EA under NDC 55466010411. Its NADAC has been published 517 times since Aug 3, 2016.
Strength
25 ug/1
Manufacturer
Neolpharma, Inc.NDC
55466010411
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
LEVOTHYROXINE SODIUMApproval Type
New Drug (NDA)
FDA Application
NDA021342On Market Since
10/29/2015
Pharmacological Classes
Price Statistics
The NADAC for LEVO-T 25 MCG TABLET has been published 517 times since Aug 3, 2016, and over the history we have for it it has declined 88.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0362 per EA |
|---|---|
| All-time high | $0.3175 (Aug 10, 2016) |
| All-time low | $0.0326 (May 22, 2024) |
| 52-week high | $0.0418 |
| 52-week low | $0.0362 |
| Median price | $0.1889 |
| Average price | $0.1704 |
| Largest weekly change | +42.8% (Jun 19, 2024) |
| Weeks tracked | 517 |
| Tracking since | Aug 3, 2016 |
Generic Alternatives
The matcher finds 4 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 4 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of LEVO-T 25 MCG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for LEVO-T 25 MCG TABLET, manufactured by Neolpharma, Inc., is $0.0362 per EA (NDC 55466010411), effective Jun 24, 2026.
How has the price of LEVO-T 25 MCG TABLET changed over time?
Over the history we have for it, the NADAC for LEVO-T 25 MCG TABLET has declined 88.6%. It has been tracked across 517 weekly CMS publications since Aug 3, 2016.
What are the highest and lowest recorded NADAC prices for LEVO-T 25 MCG TABLET?
Since Aug 3, 2016, the NADAC for LEVO-T 25 MCG TABLET has ranged from a low of $0.0326 (May 22, 2024) to a high of $0.3175 (Aug 10, 2016), with a median of $0.1889 per EA.
Are there cheaper alternatives to LEVO-T 25 MCG TABLET?
4 NADAC-published products share the same active ingredient, strength, and dosage form as LEVO-T 25 MCG TABLET, but none are currently priced below it.
Who manufactures LEVO-T 25 MCG TABLET?
LEVO-T 25 MCG TABLET (NDC 55466010411) is labeled by Neolpharma, Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification